Back to search

Japan· JP-3112001M2069

アルファカルシドール

A alfacalcidol product containing アルファカルシドール, registered in Japan by 中外製薬, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

On Japan’s NHI price listATC A11CC03

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedアルファカルシドールATCA11CC03REGISTER NO.JP-3112001M2069PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Alfacalcidol is registered in 16 of 19 countries.

Countries holding a registration under ATC A11CC03 (alfacalcidol), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 8 of them publish a price we can compare per daily dose

Alfacalcidol · ATC A11CC03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alfacalcidol costs, country by country.

Normalised to the WHO defined daily dose (1 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Alfacalcidol · price per daily dose (1 mcg)

USD · FX 28 Sept 2026

  • IT Italy$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
アルファカルシドール
Manufacturer
中外製薬
Country
Japan (JP)
ATC code
A11CC03
ATC class
Alfacalcidol
Defined daily dose
1 mcg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b38af723-e017-49d0-a316-4c5058fd5f71
GET /v1/drugs/b38af723-e017-49d0-a316-4c5058fd5f71?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.5μg1カプセル",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3112001M2069",
  "category": "内用薬",
  "price_yen": 6.3,
  "generic_name": "アルファカルシドール",
  "product_name_jp": null,
  "therapeutic_class": "3112",
  "transitional_expiry": null
}

See everything about alfacalcidol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.